MyFinsight
Home
Blog
About
Contact
Net income
$29,492K
Accounts receivable, net
-$25,528K
Depreciation and
amortization
$20,919K
Income taxes
$14,087K
Stock-based compensation
$10,191K
Accounts payable
$5,358K
Prepaid expenses and
other assets
-$2,687K
Deferred taxes
$2,515K
Non-cash operating lease
expense
$453K
Non-cash interest
$358K
Net cash and cash
equivalents provided by...
$58,375K
Effect of exchange rate
changes on cash, cash...
$156K
Canceled cashflow
$53,213K
Net change in cash,
cash equivalents,...
$25,591K
Canceled cashflow
$32,940K
Accrued expenses,
accrued compensation,...
-$20,998K
Accrued royalties
-$14,655K
Returned goods reserve
-$6,451K
Unrealized (gain) loss on
investment in equity...
$5,753K
Accrued government
rebates
-$4,737K
Inventories
$437K
Contingent consideration
fair value...
-$182K
Proceeds from stock
option exercises and...
$2,202K
Net cash and cash
equivalents used in...
-$21,616K
Net cash and cash
equivalents used in...
-$11,324K
Canceled cashflow
$2,202K
Treasury stock purchases
for restricted...
$19,755K
Principal payments on
borrowings
$4,063K
Acquisition of property and
equipment, net
$6,074K
Acquisition of product
rights, intangible...
$5,250K
Back
Back
Cash Flow
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC (ANIP)
source: myfinsight.com